References
- Ali, T., et al., 2020. Genotoxicity and repair capability of Mus musculus DNA following the oral exposure to Tramadol. Saudi Journal of Biological Sciences, 27 (1), 12–17.
- Aly, F.M., et al., 2018. Protective effects of fullerene C60 nanoparticles and virgin olive oil against genotoxicity induced by cyclophosphamide in rats. Oxidative Medicine and Cellular Longevity, 2018, 1261356.
- Carrageta, D.F., et al., 2018. Anti-obesity potential of natural methylxanthines. Journal of Functional Foods, 43, 84–94.
- Christian, M.S., and Brent, R.L., 2001. Teratogen update: evaluation of the reproductive and developmental risks of caffeine. Teratology, 64 (1), 51–78.
- Cui, D., et al., 2010. Adenosine receptor protein changes in guinea pigs with form deprivation myopia. Acta Ophthalmologica, 88 (7), 759–765.
- Cui, D., et al., 2011. Effects of 7-methylxanthine on the sclera in form deprivation myopia in guinea pigs. Acta Ophthalmologica, 89 (4), 328–334.
- Damiani, A.P., et al., 2017. A reduction in DNA damage in neural tissue and peripheral blood of old mice treated with caffeine. Journal of Toxicology and Environmental Health. Part A, 80 (13–15), 621–629.
- Ganesan, P., and Wildsoet, C.F., 2010. Pharmaceutical intervention for myopia control. Expert Review of Ophthalmology, 5 (6), 759–787.
- Gisselsson, D., 2001. Ring chromosomes: vicious circles at the end and beginning of life. Atlas Genet Cytogenet Oncol Haematol, 6, 59–66.
- Guo, L., et al., 2016. Prevalence and associated factors of myopia among primary and middle school-aged students: a school-based study in Guangzhou. Eye, 30 (6), 796–804.
- Holden, B.A., et al., 2016. Resnikoff, global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology, 123 (5), 1036–1042.
- Hornbeak, D.M., and Young, T.L., 2009. Myopia genetics: a review of current research and emerging trends. Current Opinion in Ophthalmology, 20 (5), 356–362.
- Hung, F.L., et al., 2018. Narrow-band, long-wavelength lighting promotes hyperopia and retards vision-induced myopia in infant rhesus monkeys. Experimental Eye Research, 176, 147–160.
- ICH., 2012. Guidance for industry. S2(R1) Genotoxicity testing and data interpretation for pharmaceuticals intended for human use. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. 1–35. https://www.fda.gov/media/71980/download.
- Kaur, S., et al., 2021. Modulation of mutagenicity in Salmonella typhimurium and antioxidant properties and antiproliferative effects of fractions from Cassia fistula L. on human cervical HeLa and breast MCF-7 cancer cells. Environmental Science and Pollution Research, 28 (6), 6619–6634.
- Liu, H., et al., 2020. Effects of 7-methylxanthine on deprivation myopia and retinal dopamine release in chickens. Ophthalmic Research, 63 (3), 347–357.
- Maron, D.M., and Ames, B.N., 1983. Revised methods for the Salmonella mutagenicity test. Mutation Research, 113 (3–4), 173–215.
- Mortelmans, K., and Zeiger, E., 2000. The Ames Salmonella/microsome mutagenicity assay. Mutation Research, 455 (1–2), 29–60.
- Nie, H.H., et al., 2012. Effects of 7-methylxanthine on form – deprivation myopia in pigmented rabbits. International Journal of Ophthalmology, 5 (2), 133–137.
- Numa, S., et al., 2018. Prevalence of posterior staphyloma and factors associated with its shape in the Japanese population. Scientific Report, 80, 1–10.
- OECD., 2016a. Guidelines for the Testing of Chemicals. In vivo Mammalian Alkaline Comet Assay. Guideline No. 489. OECD (Ed.). 1–25.
- OECD., 2016b. Guidelines for Testing of Chemical. Mammalian Erythrocyte Micronucleus Test. Guideline No. 474. OECD (Ed.). 1–21.
- OECD., 2016c. Guidelines for the Testing of Chemicals. Mammalian Bone Marrow Chromosome Aberration Test. Guideline No. 475. OECD (Ed.). 1–8.
- Parveen, N., et al., 2015. Prevalence of myopia and its associated risk factors in local medical students. Cell, 334, 3887822. https://www.researchgate.net/profile/Syed-Hafeezul-Hassan/publication/336917241_PREVALENCE_OF_MYOPIA_AND_ITS_ASSOCIATED_RISK_FACTORS_IN_LOCAL_MEDICAL_STUDENTS/links/5dbab7b4299bf1a47b027fec/PREVALENCE-OF-MYOPIA-AND-ITS-ASSOCIATED-RISK-FACTORS-IN-LOCAL-MEDICAL-STUDENTS.pdf
- Polkinghorne, J.P., and Craig, P.J., 2004. Northern New Zealand and Rhegmatogenous retinal development study: epidemiology and risk factors. Clinical & Experimental Ophthalmology, 32 (2), 159–163.
- Rothfuss, A., et al., 2010. Collaborative study on fifteen compounds in the rat-liver comet assay integrated into 2-and 4-week repeat-dose studies. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 702 (1), 40–69.
- Savale, K.S., 2018. Genotoxicity of drugs: introduction, prediction and evaluation. Asian Journal of Biomaterial Research, 4 (6), 1–29. https://www.researchgate.net/profile/Sagar-Savale/publication/334389865_Genotoxicity_of_Drugs_Introduction_Prediction_and_Evaluation/links/5d26e429299bf1547cab68e9/Genotoxicity-of-Drugs-Introduction-Prediction-and-Evaluation.pdf
- Saw, S.M., et al., 2002. Prevalence and risk factors associated with dry eye symptoms: a population-based study in Indonesia. Journal of Clinical Epidemiology, 43, 332–339.
- Saw, S.W., et al., 1996. Epidemology of myopia. Epidemiologic Reviews, 18 (2), 175–187.
- Schmidt, W., 1976. The micronucleus test for cytogenetic analysis. In chemical mutagens. Principles and Methods for Their Detection, 4, 31–53.
- Siatkowski, R.M., et al., 2008. Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Journal of AAPOS, 12 (4), 332–339.
- Singh, H., et al., 2021. Pre-clinical and cellular toxicity evaluation of 7-methylxanthine: an investigational drug for the treatment of myopia. Drug and Chemical Toxicology, 44 (6), 575–584..
- Singh, H., et al., 2022. Sub-chronic and chronic toxicity evaluation of 7-methylxanthine: a new molecule for the treatment of myopia. Drug and Chemical Toxicology, 45 (3), 1383–1394.
- Singh, N.P., et al., 1988. A simple technique for quantification of low levels of DNA damage in individual cells. Experimental Cell Research, 175 (1), 184–191.
- Tan, Z., et al., 2018. Mammalian cells undergo endoreduplication in response to lactic acidosis. Scientific Report, 8 (1), 1–10.
- Trier, K., et al., 1999. Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, orl-ornithine. The British Journal of Ophthalmology, 83 (12), 1370–1375. https://bjo.bmj.com/content/bjophthalmol/83/12/1370.full.pdf
- Trier, K., et al., 2008. Systemic 7- methylxanthine in retarding axial eye growth and myopia progression – a 36-month pilot study. Journal of Ocular Biology, Diseases, and Informatics, 1 (2–4), 85–93.
- Trier, K., et al., 2022. Oral administration of caffeine metabolite 7-methylxanthine is associated with slowed myopia progression in Danish children. British Journal of Ophthalmology, bjophthalmol-2021-320920. doi:10.1136/bjo-2021-320920.
- Tsai, C.D., et al., 2016. Myopia development among young school children: the myopia investigator study in Taipei. Investigative Ophthalmology & Visual Science, 57 (15), 6852–6860.
- Williams, K.M., et al., 2015. Increasing prevalence of myopia in Europe and the impact of education. Ophthalmology, 122 (7), 1489–1497.
- Zeiger, E., 2001. Mutagens that are not carcinogenic: faulty theory or faulty tests. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 492 (1–2), 29–38.